DrugPatentWatch Database Preview
SELEGILINE HYDROCHLORIDE Drug Profile
or, see our see our flat-rate plans
When do Selegiline Hydrochloride patents expire, and what generic alternatives are available?
The generic ingredient in SELEGILINE HYDROCHLORIDE is selegiline hydrochloride. There are seventeen drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the selegiline hydrochloride profile page.
Summary for SELEGILINE HYDROCHLORIDE
| US Patents: | 0 |
| Applicants: | 10 |
| NDAs: | 13 |
| Suppliers / Packagers: | 7 |
| Bulk Api Vendors: | 45 |
| Clinical Trials: | 33 |
| Patent Applications: | 522 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | SELEGILINE HYDROCHLORIDE at DailyMed |
Pharmacology for SELEGILINE HYDROCHLORIDE
| Drug Class | Monoamine Oxidase Inhibitor Monoamine Oxidase Type B Inhibitor |
| Mechanism of Action | Monoamine Oxidase Inhibitors Monoamine Oxidase-B Inhibitors |
Synonyms for SELEGILINE HYDROCHLORIDE
| (-)-(R)-N,alpha-Dimethyl-N-2-propynylphenethylamine hydrochloride |
| (-)-(R)-N,alpha-Dimethyl-N-2-propynylphenethylamine monohydrochloride |
| (-)-Deprenil hydrochloride |
| (-)-Deprenyl hydrochloride |
| (-)-E-250 hydrochloride |
| (-)-N,alpha-Dimethyl-N-2-propynylbenzeneethanamine hydrochloride |
| (-)-Phenylisopropylmethylpropynylamine |
| (2R)-N-methyl-1-phenyl-N-prop-2-ynylpropan-2-amine hydrochloride |
| (2R)-N-methyl-1-phenyl-N-prop-2-ynylpropan-2-amine;hydrochloride |
| (R)-(-)-Deprenyl hydrochloride |
| (R)-(-)-N-?-Dimethyl-N-2-propynylbenzeneethanamine hydrochloride |
| (R)-(-)-N,alpha-Dimethyl-N-(2-propynyl)phenethylamine hydrochloride |
| (R)-N-Methyl-N-(1-phenylpropan-2-yl)prop-2-yn-1-amine hydrochloride |
| (R)-N-Methyl-N-(1-phenylpropan-2-yl)prop-2-yn-1-aminehydrochloride |
| 14611-51-9 (Parent) |
| 14611-52-0 |
| 40602-63-9 |
| 611S520 |
| 6W731X367Q |
| AC-18759 |
| AC1L1BU2 |
| AK115813 |
| AKOS005166822 |
| Ambap14611-52-0 |
| API0004151 |
| AX8151001 |
| Benzeneethanamine, N,alpha-dimethyl-N-2-propynyl-, hydrochloride, (R)- |
| BG0405 |
| Bio-0098 |
| C13H17N.HCl |
| CAS-14611-52-0 |
| CC-34395 |
| CCG-100773 |
| CCRIS 8571 |
| CHEBI:9087 |
| CHEMBL1200904 |
| CPD000449328 |
| CS-2764 |
| D00785 |
| D0J2MJ |
| D0OH5I |
| D0Y8AN |
| DSSTox_CID_24584 |
| DSSTox_GSID_44584 |
| DSSTox_RID_80331 |
| DTXSID9044584 |
| E-250 |
| Eldepryl |
| Eldepryl (TN) |
| Eldepryl hydrochloride |
| Ensam |
| FPF-1100 |
| FPF1100 |
| FT-0601539 |
| HMS1569P05 |
| HSDB 7183 |
| HY-14199 |
| IYETZZCWLLUHIJ-UTONKHPSSA-N |
| Jumex hydrochloride |
| K-4669 |
| KS-00000059 |
| KS-5098 |
| L-Deprenyl |
| l-Deprenyl hydrochloride |
| LS-30157 |
| MFCD00069299 |
| MLS000758294 |
| MLS001423947 |
| MLS002153281 |
| MLS002222269 |
| NC00023 |
| NC00605 |
| NCGC00016708-01 |
| NCGC00024994-06 |
| NCGC00255797-01 |
| Otrasel |
| Plurimen |
| Prestwick_846 |
| R-(-)-Deprenyl (hydrochloride) |
| R-(-)-Deprenyl hydrochloride |
| R-(-)-Deprenyl hydrochloride, powder, >=98% (HPLC) |
| R-(-)deprenyl hydrochloride |
| SAM001246969 |
| SAM002589926 |
| SCHEMBL41392 |
| Seledat |
| Selegiline Hcl |
| Selegiline hydrochloride (JAN/USP) |
| Selegiline hydrochloride [USAN:USP] |
| Selegiline hydrochloride [USAN] |
| Selegiline Hydrochloride 1.0 mg/ml in Methanol (as free base) |
| Selegiline hydrochloride, European Pharmacopoeia (EP) Reference Standard |
| Selegiline hydrochloride, United States Pharmacopeia (USP) Reference Standard |
| SMR000449328 |
| SR-01000597928 |
| SR-01000597928-5 |
| ST24035592 |
| Tox21_110572 |
| Tox21_110572_1 |
| Tox21_301846 |
| UNII-63G7R4955A component IYETZZCWLLUHIJ-UTONKHPSSA-N |
| UNII-6W731X367Q |
| Vivapryl |
| Xilopar |
| Zelapar |
| Zydis selegiline |
US Patents and Regulatory Information for SELEGILINE HYDROCHLORIDE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apotex | SELEGILINE HYDROCHLORIDE | selegiline hydrochloride | CAPSULE;ORAL | 075321-001 | Dec 4, 1998 | AB | RX | No | No | ➤ Try a Free Trial | ➤ Try a Free Trial | ➤ Try a Free Trial | |||
| Chartwell Molecules | SELEGILINE HYDROCHLORIDE | selegiline hydrochloride | TABLET;ORAL | 074641-001 | Aug 2, 1996 | DISCN | No | No | ➤ Try a Free Trial | ➤ Try a Free Trial | ➤ Try a Free Trial | ||||
| Apotex Inc | SELEGILINE HYDROCHLORIDE | selegiline hydrochloride | TABLET;ORAL | 074871-001 | Jun 6, 1997 | AB | RX | No | Yes | ➤ Try a Free Trial | ➤ Try a Free Trial | ➤ Try a Free Trial | |||
| Siegfried | SELEGILINE HYDROCHLORIDE | selegiline hydrochloride | TABLET;ORAL | 074672-001 | Apr 1, 1997 | DISCN | No | No | ➤ Try a Free Trial | ➤ Try a Free Trial | ➤ Try a Free Trial | ||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
or, see our see our flat-rate plans
or, see our see our flat-rate plans
